Q92736 (RYR2_HUMAN) Homo sapiens (Human)
Ryanodine receptor 2 UniProtKBInterProSTRINGInteractive Modelling
4967 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
26 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structure of PKA phosphorylated human RyR2-R2474S in the closed state in the presence of ARM210 |
Heteromer P68106; | 4×ZN; 8×ATP; 4×KVR; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2-R2474S in the open state in the presence of Calmodulin |
Heteromer P0DP23; P68106; | 4×ZN; 8×ATP; 4×CA; 4×XAN; | ||||
| Assess | ||||||
| Structure of dephosphorylated human RyR2 in the closed state |
Heteromer P68106; | 4×ZN; 8×ATP; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2-R420Q in the primed state |
Heteromer P68106; | 4×ZN; 8×ATP; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2-R2474S in the open state |
Heteromer P68106; | 4×ZN; 8×ATP; 4×CA; 4×XAN; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2-R420Q in the closed state in the presence of ARM210 |
Heteromer P68106; | 4×ZN; 8×ATP; 4×KVR; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2-R420W in the primed state |
Heteromer P68106; | 4×ZN; 8×ATP; | ||||
| Assess | ||||||
| Structure of dephosphorylated human RyR2 in the open state |
Heteromer P68106; | 4×ZN; 8×ATP; 4×CA; 4×XAN; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2-R2474S in the closed state |
Heteromer P68106; | 4×ZN; 8×ATP; | ||||
| Assess | ||||||
| Structure of human RyR2-S2808D in the subprimed state |
Heteromer P68106; | 4×ZN; 8×ATP; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2-R420W in the primed state in the presence of calcium and… |
Heteromer P0DP23; P68106; | 4×ZN; 8×ATP; 20×CA; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2-R420W in the open state in the presence of calcium and c… |
Heteromer P0DP23; P68106; | 20×CA; 4×ZN; 8×ATP; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2 in the closed state |
Heteromer P68106; | 4×ZN; 8×ATP; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2-R420W in the closed state in the presence of ARM210 |
Heteromer P68106; | 4×ZN; 8×ATP; 4×KVR; | ||||
| Assess | ||||||
| Structure of human RyR2-S2808D in the closed state in the presence of ARM210 |
Heteromer P68106; | 4×ZN; 8×ATP; 4×KVR; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2-R420W in the primed state in the presence of calcium |
Heteromer P68106; | 4×ZN; 8×ATP; 4×CA; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2 in the closed state in the presence of Calmodulin |
Heteromer P0DP23; P68106; | 4×ZN; 8×ATP; | ||||
| Assess | ||||||
| Structure of human RyR2-S2808D in the subprimed state in the presence of H2O2/NOC-12/GSH |
Heteromer P68106; | 4×ZN; 8×ATP; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2-R2474S in the closed state in the presence of Calmodulin |
Heteromer P0DP23; P68106; | 4×ZN; 8×ATP; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2-R420W in the open state in the presence of calcium |
Heteromer P68106; | 4×ZN; 8×ATP; 4×CA; | ||||
| Assess | ||||||
| Structure of PKA phosphorylated human RyR2 in the open state |
Heteromer P68106; | 4×ZN; 8×ATP; 4×CA; 4×XAN; | ||||
| Assess | ||||||
| Structure of Calmodulin Bound to the Cardiac Ryanodine Receptor (RyR2) at Residues: Phe4246 to Val4… |
Heteromer P0DP23; | 5×CA; 4×EDO; | ||||
| Assess | ||||||
| Calmodulin N53I variant bound to cardiac ryanodine receptor (RyR2) calmodulin binding domain |
Heteromer P0DP23; | 4×CA; | ||||
| Assess | ||||||
| Calmodulin bound to cardiac ryanodine receptor (RyR2) calmodulin binding domain |
Heteromer P0DP23; | 4×CA; | ||||
| Assess | ||||||
| Structure of human RyR2-S2808D in the primed state in the presence of Rapamycin | homo-4-mer | 4×ZN; 8×ATP; | ||||
| Assess | ||||||
| Crystal structure of the N-terminal region of the human ryanodine receptor 2 | monomer | |||||
| Assess | ||||||
7 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8uq2.1.A | monomer | 0.72 | 1×ZN; 2×ATP; | 99.98 | ||
| Assess | ||||||
| 7tzc.1.I | monomer | 0.70 | 1×ATP; 1×ZN; 1×CFF; 1×KVR; | 66.57 | ||
| Assess | ||||||
| 8dve.1.D | monomer | 0.64 | 1×CFF; 1×CA; 1×ATP; 1×ZN; | 66.57 | ||
| Assess | ||||||
| 3j8h.1.A | monomer | 0.55 | 1×ZN; | 58.44 | ||
| Assess | ||||||
| 6x34.1.B | monomer | 0.55 | 1×ZN; | 67.47 | ||
| Assess | ||||||
| 5l1d.1.A | monomer | 0.51 | 89.14 | |||
| Assess | ||||||
| 6x36.1.B | monomer | 0.51 | 67.02 | |||
| Assess | ||||||
7 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 7u9r.1.B | monomer | 0.71 | 1×ZN; 2×ATP; 1×XAN; | 100.00 | |
| Assess | ||||||
| Isoform 2 | 7tzc.1.I | monomer | 0.70 | 1×ATP; 1×ZN; 1×KVR; | 66.44 | |
| Assess | ||||||
| Isoform 2 | 8dve.1.D | monomer | 0.64 | 1×CA; 1×ATP; 1×ZN; | 66.44 | |
| Assess | ||||||
| Isoform 2 | 3j8h.1.A | monomer | 0.55 | 1×ZN; | 58.28 | |
| Assess | ||||||
| Isoform 2 | 6x34.1.B | monomer | 0.55 | 1×ZN; | 67.44 | |
| Assess | ||||||
| Isoform 2 | 5l1d.1.A | monomer | 0.52 | 89.12 | ||
| Assess | ||||||
| Isoform 2 | 6x36.1.B | monomer | 0.51 | 66.93 | ||
| Assess | ||||||